These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa. Cronjé N; Schwartz IS; Retief L; Bastos ADS; Matthee S; Preiser W; Bennett NC; Maphanga T; Govender NP; Colebunders R; Kenyon C Med Mycol; 2018 Jun; 56(4):510-513. PubMed ID: 28992307 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp. Trzoss M; Covel JA; Kapoor M; Moloney MK; Soltow QA; Webb PJ; Shaw KJ Bioorg Med Chem Lett; 2019 Dec; 29(23):126713. PubMed ID: 31668974 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. Espinel-Ingroff A J Clin Microbiol; 1998 Jan; 36(1):198-202. PubMed ID: 9431946 [TBL] [Abstract][Full Text] [Related]
27. Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America. Schwartz IS; Sanche S; Wiederhold NP; Patterson TF; Sigler L Emerg Infect Dis; 2018 Apr; 24(4):758-761. PubMed ID: 29553321 [TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testing. Messer SA; Pfaller MA Diagn Microbiol Infect Dis; 1996 Jun; 25(2):77-81. PubMed ID: 8882893 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Sugar AM; Liu XP Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of fungal diseases in Africa: A review of diagnostic drivers. Bongomin F; Adetona Fayemiwo S Curr Med Mycol; 2021 Mar; 7(1):63-70. PubMed ID: 34553101 [TBL] [Abstract][Full Text] [Related]
31. The Role of Isavuconazonium Sulphate for the Treatment of Blastomycosis: A Case Series and Antifungal Susceptibility. Scolarici MJ; King C; Sterkel A; Smith J; Gauthier G; Saddler C Open Forum Infect Dis; 2022 Jul; 9(7):ofac220. PubMed ID: 35821730 [TBL] [Abstract][Full Text] [Related]
32. Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing. Wiederhold NP Methods Mol Biol; 2023; 2658():3-16. PubMed ID: 37024691 [TBL] [Abstract][Full Text] [Related]
33. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743 [TBL] [Abstract][Full Text] [Related]
34. Molecular detection of airborne Emergomyces africanus, a thermally dimorphic fungal pathogen, in Cape Town, South Africa. Schwartz IS; McLoud JD; Berman D; Botha A; Lerm B; Colebunders R; Levetin E; Kenyon C PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006174. PubMed ID: 29357352 [TBL] [Abstract][Full Text] [Related]
36. Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates Badali H; Patterson HP; Sanders CJ; Mermella B; Gibas CFC; Ibrahim AS; Shaw KJ; Wiederhold NP Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722886 [TBL] [Abstract][Full Text] [Related]
37. Factors influencing susceptibility testing of antifungal drugs: a critical review of document M27-A4 from the Clinical and Laboratory Standards Institute (CLSI). de Sousa ESO; Cortez ACA; de Souza Carvalho Melhem M; Frickmann H; de Souza JVB Braz J Microbiol; 2020 Dec; 51(4):1791-1800. PubMed ID: 32757139 [TBL] [Abstract][Full Text] [Related]
38. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections. Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295 [TBL] [Abstract][Full Text] [Related]
39. Voriconazole activity against clinical yeast isolates: a multicentre Italian study. Morace G; Polonelli L; Int J Antimicrob Agents; 2005 Sep; 26(3):247-53. PubMed ID: 16051469 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]